Left to right, Chicago Mayor Rahm Emanuel; Bill Vick, PF Warriors; Teresa Barnes, patient advocate; Tom Hurvis, Three Lakes Partners; Steven Collens, MATTER; and Ken Bahk, Three Lakes Partners. Photo Credit: Sean Su | CloudSpotter A group of philanthropists, medical-tech and business people have issued…
Chicago Group Issues $1 Million Challenge on Solutions for Pulmonary Fibrosis
As the weather gets warmer here in Canada and everything begins to bloom for another year, it means summer is just a few weeks away. Summer has always been my favorite season. I love the warmth it brings because I despise being cold. I also love the…
Pulmonary fibrosis (PF) patients are susceptible to lung infections which can often lead to hospitalization. According to the American Lung Association, there are several things you can do to help prevent lung infections. Practice Good Hygiene Regularly washing hands with soap and water — particularly before eating…
Pulmonary fibrosis (PF) is a progressive chronic lung disease where the tissue in the lungs becomes scarred and stiffens. This can lead to a multitude of symptoms including breathlessness, persistent coughing, fatigue, joint pain and for some patients, weight loss. Pulmonary fibrosis symptoms: Aching joints and muscles Weight loss…
Throughout my childhood, adolescent years and most recently young adulthood, I have been my toughest critic. I openly admit to that, and have had a strong desire to always want to do things to the best of my ability. I will repeat an activity or task until I have…
MiRagen Therapeutics‘ MRG-201 has reversed fibrosis in mice with pulmonary fibrosis, according to a presentation the company prepared for the 76th annual meeting of the Society for Investigative Dermatology in Portland, Oregon. The biopharmaceutical firm develops fibrosis treatments that target microRNAs, small molecules that control whether genes are switched on or…
Ofev (nintedanib) is a drug used in the treatment of idiopathic pulmonary fibrosis (IPF). The anti-fibrotic therapy is made by the pharmaceutical company Boehringer Ingelheim and was approved by the FDA in October 2014 and by the European Commission in January 2015. MORE: New knowledge about Ofev and Esbriet may…
Natural gene variants, called polymorphisms, may explain why some patients with systemic sclerosis also develop pulmonary fibrosis (PF). The study, “The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms,” appeared in the journal Rheumatology International. PF is one of the leading…
Since being diagnosed with idiopathic pulmonary fibrosis (IPF), it has been interesting to observe how certain movie quotes seem to have much more meaning than they did prior to my diagnosis. I tend to watch movies these days seeking out characters who can relate to what it…
Pulmonary fibrosis (PF) is a chronic lung disease where the tissue in the lungs becomes scarred and stiffens over time. Like all diseases, PF does not discriminate and there have been many celebrities who have suffered from the condition. Sadly, some have lost their lives to the disease. According to…
